J. Goldman & Co LP

Position in HIMS — Hims & Hers Health, Inc.

CIK 1412741 NEW YORK, NY

Back to HIMS Full portfolio

Position in HIMS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$386,223

-$4,135,428 QoQ

Shares Held

11,140

-95.0% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#292

of 504 holders

Holding Since

Jun 2022

7 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in HIMS Over Time

Shares Held

Position Value (USD)

Derivatives in HIMS

reported options exposure · as of Jun 30, 2026

CallValue

$811,278

CallShares

23,400

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

J. Goldman & Co LP holds $3,690,441 across 4 Drug Manufacturers - Specialty & Generic names. HIMS ranks #4 (10.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LQDA	Liquidia Corp	22,200	$1,770,006
2	DERM	Journey Medical Corp	137,584	$974,094
3	PCRX	Pacira BioSciences, Inc.	22,078	$560,118
4	HIMS	Hims & Hers Health, Inc. This page	11,140	$386,223

All Filings in HIMS

Export CSV

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$811,278	23,400	—	Call	Sole	2026-08-14
2026-06-30	$386,223	11,140	-95.0%	Shares	Sole	2026-08-14
2024-06-30	$4,521,651	223,955	+218.6%	Shares	Sole	2024-08-14
2023-09-30	$442,080	70,283	+13.2%	Shares	Sole	2023-11-14
2023-03-31	$615,873	62,084	-94.5%	Shares	Sole	2023-05-15
2022-12-31	$7,209,653	1,124,751	+98.0%	Shares	Sole	2023-02-14
2022-09-30	$3,169,032	567,927	-64.6%	Shares	Sole	2022-11-14
2022-06-30	$7,274,074	1,605,756	—	Shares	Sole	2022-08-15
No filing history on record for this holder in this stock.